MORACE, Carmela
 Distribuzione geografica
Continente #
EU - Europa 3.048
NA - Nord America 2.139
AS - Asia 1.541
SA - Sud America 449
AF - Africa 50
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.230
Nazione #
US - Stati Uniti d'America 2.090
RU - Federazione Russa 1.711
SG - Singapore 582
CN - Cina 443
BR - Brasile 375
IE - Irlanda 329
SE - Svezia 284
IT - Italia 200
HK - Hong Kong 198
DE - Germania 134
VN - Vietnam 113
FR - Francia 84
FI - Finlandia 82
IN - India 62
GB - Regno Unito 56
PL - Polonia 39
UA - Ucraina 28
AR - Argentina 25
EE - Estonia 21
CA - Canada 19
MX - Messico 19
BD - Bangladesh 18
BE - Belgio 18
TR - Turchia 17
AT - Austria 14
IQ - Iraq 14
ES - Italia 13
PK - Pakistan 13
ID - Indonesia 12
EC - Ecuador 11
MA - Marocco 11
VE - Venezuela 11
NL - Olanda 10
UZ - Uzbekistan 10
CO - Colombia 9
ZA - Sudafrica 9
CI - Costa d'Avorio 8
CZ - Repubblica Ceca 8
JP - Giappone 8
KE - Kenya 8
AE - Emirati Arabi Uniti 7
LT - Lituania 7
KG - Kirghizistan 5
MY - Malesia 5
NP - Nepal 5
PH - Filippine 5
TN - Tunisia 5
CL - Cile 4
EG - Egitto 4
IL - Israele 4
PE - Perù 4
PT - Portogallo 4
SA - Arabia Saudita 4
BO - Bolivia 3
CR - Costa Rica 3
JO - Giordania 3
KZ - Kazakistan 3
PY - Paraguay 3
UY - Uruguay 3
DO - Repubblica Dominicana 2
HU - Ungheria 2
OM - Oman 2
TG - Togo 2
TT - Trinidad e Tobago 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
CM - Camerun 1
DZ - Algeria 1
GA - Gabon 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
KR - Corea 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
PA - Panama 1
PG - Papua Nuova Guinea 1
QA - Qatar 1
SR - Suriname 1
TH - Thailandia 1
TM - Turkmenistan 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.230
Città #
Moscow 477
Ashburn 382
Singapore 337
Dublin 329
Dallas 238
Chandler 205
Hong Kong 198
Beijing 145
Nyköping 136
San Jose 109
Jacksonville 85
The Dalles 84
Los Angeles 67
Messina 61
Munich 56
Ann Arbor 52
Medford 44
Princeton 44
Dearborn 39
Lauterbourg 39
Cambridge 37
Des Moines 35
Ho Chi Minh City 34
Warsaw 34
New York 33
São Paulo 30
Hanoi 27
Buffalo 22
Turku 22
Nuremberg 21
Pune 21
Chennai 19
Boardman 18
Tianjin 18
Brussels 17
Brooklyn 15
Catania 15
Helsinki 14
Santa Clara 14
Lancaster 13
Woodbridge 13
Bremen 12
Frankfurt am Main 12
Guangzhou 12
Redondo Beach 12
Salerno 12
Haikou 11
Montreal 11
Orem 11
Shenyang 11
Stockholm 11
Chicago 10
Rio de Janeiro 10
Bari 9
Council Bluffs 9
Houston 9
Jinan 9
Shanghai 9
Tashkent 9
Abidjan 8
Amsterdam 8
Düsseldorf 8
Jakarta 8
Mexico City 8
San Mateo 8
Vienna 8
Belo Horizonte 7
Brasília 7
Denver 7
Haiphong 7
Hyderabad 7
Nanjing 7
Shenzhen 7
Tokyo 7
Espoo 6
Johannesburg 6
Manchester 6
Nairobi 6
Scandicci 6
Zhengzhou 6
Atlanta 5
Bishkek 5
Brno 5
Casablanca 5
Curitiba 5
Feira de Santana 5
Kunming 5
Lahore 5
London 5
Maringá 5
New Delhi 5
Palermo 5
Poplar 5
Recife 5
Salvador 5
San Francisco 5
Seattle 5
Sumaré 5
Vittoria 5
Washington 5
Totale 4.036
Nome #
Abnormal left ventricular global strain during exercise-test in young healthy smokers 258
Biglycan expression, earlier vascular damage and pro-atherogenic profile improvement after smoke cessation in young people. 239
CD34+ cell count predicts long lasting life in the oldest old. 203
A comparison of uncovered metal stents for the palliation of patients withmalignant biliary obstruction: nitinol vs. stainless steel 201
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma 195
Circulating progenitor cells in hypertensive subjects: Effectiveness of a treatment with olmesartan in improving cell number and miR profile in addition to expected pharmacological effects. 192
High serum resistin in chronic viral hepatitis is not a marker of metabolic disorder. 188
Insulin-like growth factor-II is a useful marker to detect hepatocellular carcinoma? 182
Expression and change of mirs 145, 221 and 222 in hypertensive subjects treated with enalapril, losartan or olmesartan 170
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 168
Arterial Stiffness and Adult Onset Vasculitis: A Systematic Review 166
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia 157
Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits. 154
Negative emotions in irritable bowel syndrome: which differences among IBS subtypes? 150
The real-world effectiveness of intravenous brivaracetam as a second-line treatment in status epilepticus 147
High circulating D-dimers are associated with ascites and hepatocellularcarcinoma in liver cirrhosis. 142
Carbon dioxide insufflation versus air insufflation during endoscopic retrograde cholangiopancreatography under general anesthesia. 139
Endocan and circulating progenitor cells in women with systemic sclerosis: Association with inflammation and pulmonary hypertension 138
PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy 132
Prognostic factors of survival in complicated viral and alcoholic cirrhosis without hepatocellular carcinoma. A retrospective study. 131
Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units 129
High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis. 126
Complications of endoscopic ultrasonography. 126
Current practice of hepatitis C treatment in Southern Italy. 125
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma. 123
Endoscopic resection as a safe and effective technique for treatment of pedunculated and non-pedunculated benign-appearing colorectal neoplasms measuring 40 mm or more in size 118
Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs? 118
Pancreatic necrosectomy: an evidence-based systematic review of the levels of evidence and a comparison of endoscopic versus non-endoscopic techniques. 117
Endoscopic tattooing of gastrointestinal and pancreatic lesions. 115
Endoscopic management of bile duct injury after hepatobiliary tract surgery: a comprehensive review. 114
High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease 112
Current practice of chronic hepatitis B treatment in Southern Italy. 111
Outcomes of Radiofrequency Ablation for Dysplastic Barrett's Esophagus: A Comprehensive Review 109
Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patients 106
Cholangioscopy using a new type of cholangioscope for the diagnosis of biliary tract disease: a case series. 103
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 103
On the efficacy of penicillins for Helicobacter pylori eradication 101
Short- and long-term outcomes of self-expanding metal stent placement as a bridgeto surgery for acute left-sided colorectal cancer obstruction 89
Unlocking the Predictive Power of Nutritional Scores in Septic Patients 87
Through-the-scope large diameter self-expanding metal stent placement as a safe and effective technique for palliation of malignant colorectal obstruction: a single center experience with a long-term follow-up 87
Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Calcium Homeostasis: Where We Stand Now 83
Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease 83
High Serum Resistin in Chronic Viral Hepatitis Is not a Marker of Metabolic Disorder 83
Endoscopic marking methods 82
null 81
Liver steatosis in celiac disease: the open door. 80
Molecular findings on Helicobacter pylori: update for clinicians. 78
Placement of a new fully covered self-expanding metal stent for postoperative biliary strictures and leaks not responding to plastic stenting. 77
Minerva Gastroenterol Dietol 76
GastroPanel® test for non-invasive diagnosis of atrophic gastritis in patients with dyspepsia. 75
Is Helicobacter pylori the infectious target to prevent gastric cancer? An interdisciplinary point of view. 75
Expanding the Use of SGLT2 Inhibitors in T2D Patients Across Clinical Settings 73
Current practice of hepatitis C treatment in Southern Italy. 72
Retrospective Analysis of Fever in Pediatric Age: Our Experience over the Last 5 Years 69
Is pregnancy a predisposing factor for Dieulafoy's duodenal lesion or only a coincidence? 69
null 67
THE MULTIPLE EFFECTS OF VITAMIN D ON CHRONIC DISEASES 64
Impact of Coronavirus Disease 2019 Lockdown on Quality of Life and Locus of Control in Elderly Subjects with Type 2 Diabetes 63
Short- and long-term outcomes of self-expanding metal stent placement as a bridge to surgery for acute left-sided colorectal cancer obstruction. 59
Through-the-scope large diameter self-expanding metal stent placement as a safeand effective technique for palliation of malignant colorectal obstruction: asingle center experience with a long-term follow-up 53
null 52
Ketoacidosis and SGLT2 Inhibitors: A Narrative Review 50
null 39
Cardiovascular Risk Assessments and Ultrasound-Assisted Re-Stratification in Patients with Inflammatory Bowel Disease (IBD) 36
null 27
null 24
Trabecular bone score enhances fracture risk stratification in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus 3
Totale 7.364
Categoria #
all - tutte 23.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.737


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202154 0 0 0 0 0 0 0 0 0 25 14 15
2021/2022314 5 22 8 9 10 0 18 8 2 82 49 101
2022/2023845 60 98 38 53 52 68 8 57 377 4 23 7
2023/2024309 11 33 21 39 23 68 3 20 7 24 29 31
2024/20251.363 17 27 12 103 63 70 47 191 301 127 129 276
2025/20263.878 253 234 286 284 345 772 466 532 528 178 0 0
Totale 7.364